MLB · Thu, Apr 21
Final
W: Zach Plesac · L: Dylan Cease · SV: Emmanuel Clase
| Team | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | R | H | E |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CWS | 0 | 0 | 0 | 1 | 0 | 0 | 2 | 0 | 0 | 3 | 8 | 2 |
| CLE | 0 | 0 | 2 | 0 | 1 | 1 | 2 | 0 | – | 6 | 13 | 2 |
Win probability
CLE 100%CLE 99%
CWS 100%model, computed at ingest
Key plays
HR/F89XD.3-H0–2 · 78%
W0–2 · 68%
D9/F9D.2XH(942);1-30–2 · 70%
9/SF/F9LS.3-H1–2 · 63%
7/L78D+1–2 · 68%
S8/G4.2-H;1-31–3 · 82%
9/L9D+1–3 · 79%
7/SF/L7D.3-H1–4 · 92%
E1/TH/G23.2-H(NR)(UR);1-H(E4/TH)(NR)(UR);B-23–4 · 69%
K3–4 · 71%
D9/G3+.1-H3–5 · 90%
7/SF/F7D.3-H(UR)3–6 · 95%
Full play-by-play (76)
8/F8XD0–0 · 53%
K0–0 · 55%
43/G340–0 · 55%
7/F7LS0–0 · 53%
E6/TH/G6.B-10–0 · 53%
K0–0 · 53%
S7/G56.1-20–0 · 53%
53/G6S0–0 · 55%
63/G560–0 · 53%
1/G34S0–0 · 55%
K0–0 · 55%
D7/G50–0 · 56%
6/P8S0–0 · 58%
9/F89S0–0 · 54%
5/L50–0 · 54%
S7/G50–0 · 50%
64(1)3/GDP/G6+0–0 · 54%
S8/L78S0–0 · 55%
8/L89XD+0–0 · 54%
D9/L89D0–0 · 56%
63/G60–0 · 59%
3/G3.2-30–0 · 54%
HR/F89XD.3-H0–2 · 78%
63/G6M0–2 · 76%
D7/L78XD+0–2 · 76%
W0–2 · 68%
D9/F9D.2XH(942);1-30–2 · 70%
9/SF/F9LS.3-H1–2 · 63%
S5/G5.2-31–2 · 66%
4/L34D+1–2 · 64%
13/G34S1–2 · 68%
W1–2 · 68%
9/F9S1–2 · 67%
SB21–2 · 67%
63/G61–2 · 68%
7/L78D+1–2 · 68%
K1–2 · 71%
53/G561–2 · 71%
W1–2 · 72%
K1–2 · 72%
S5/G56S-.1-21–2 · 72%
K1–2 · 71%
S8/G4.2-H;1-31–3 · 82%
13/G1S-1–3 · 83%
S9/L9LS1–3 · 79%
9/L9D+1–3 · 79%
CS2(24)1–3 · 83%
9/F9D1–3 · 84%
S9/G34+1–3 · 85%
S7/L7S.1-21–3 · 87%
24/SH/BG2.2-3;1-21–3 · 87%
7/SF/L7D.3-H1–4 · 92%
S4/G4M.2-31–4 · 91%
63/G61–4 · 92%
9/F9S1–4 · 93%
8/L8D+1–4 · 94%
S49/G34+1–4 · 94%
S7/L78+.1-21–4 · 93%
E1/TH/G23.2-H(NR)(UR);1-H(E4/TH)(NR)(UR);B-23–4 · 69%
K3–4 · 71%
S8/G6M3–4 · 77%
D9/G3+.1-H3–5 · 90%
FC6/G56.2-3(E6);B-13–5 · 91%
7/SF/F7D.3-H(UR)3–6 · 95%
64(1)3/GDP/G63–6 · 94%
63/G56D3–6 · 95%
K3–6 · 96%
K3–6 · 96%
S7/L73–6 · 97%
3/P1S-3–6 · 97%
K3–6 · 97%
S4/G4.1-23–6 · 97%
3/G34+3–6 · 97%
6/L6M3–6 · 98%
7/F783–6 · 99%
63/G63–6 · 99%
Betting
No odds snapshots ingested for this game yet.
Comments (0)
Log in to join the conversation.